LINCOLN PHARMACEUTICALS LTD.
BSE: 531633
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 177.28-5.3% | 187.28+12.6% | 166.32+1.8% | 163.36+6.0% | 154.07-8.4% | 168.18+14.8% | 146.55-9.1% | 161.21 |
| Other Income | 24.26+678.4% | -4.20-127.7% | 15.15+109.4% | 7.23-52.6% | 15.27+322.0% | -6.88-176.7% | 8.97-10.1% | 9.98 |
| Total Income | 201.55+10.1% | 183.08+0.9% | 181.47+6.4% | 170.60+0.7% | 169.34+5.0% | 161.30+3.7% | 155.52-9.2% | 171.19 |
| EXPENSES | ||||||||
| Expenditure | 153.99-7.4% | 166.38+13.4% | 146.75+3.5% | 141.79+5.8% | 133.95-7.7% | 145.06+14.4% | 126.84-7.0% | 136.41 |
| Tax | 11.32+123.3% | 5.07-17.2% | 6.12-30.6% | 8.83+14.4% | 7.71+65.1% | 4.67-41.0% | 7.91-6.4% | 8.45 |
| PROFIT | ||||||||
| PBT | 47.55+184.7% | 16.70-51.9% | 34.72+20.5% | 28.81-18.6% | 35.39+117.8% | 16.25-43.4% | 28.68-17.5% | 34.78 |
| Net Profit | 36.23+211.4% | 11.63-59.3% | 28.60+43.1% | 19.98-27.8% | 27.68+139.1% | 11.57-44.3% | 20.77-21.1% | 26.33 |
| KEY METRICS | ||||||||
| OPM % | 15.47%+2.20pp | 13.27%-0.92pp | 14.19%-1.38pp | 15.57%+0.12pp | 15.45%-0.44pp | 15.89%+5.14pp | 10.75%-2.42pp | 13.17% |
| NPM % | 17.98%+11.63pp | 6.35%-9.41pp | 15.76%+4.05pp | 11.71%-4.63pp | 16.34%+9.16pp | 7.18%-6.17pp | 13.35%-2.03pp | 15.38% |
| EPS | 18.09+211.4% | 5.81-59.3% | 14.28+43.1% | 9.98-27.8% | 13.82+139.1% | 5.78-44.3% | 10.37-21.1% | 13.15 |
Corporate Events
Board Meeting
The 32nd Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
considering and approving un-audited financial results, any …
BSE Filing ↗Board Meeting
considering and approving unaudited financial results, any o…
BSE Filing ↗Board Meeting
Consider and approve the audited (standalone and consolidate…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
Consider and approve un-audited financial results (standalon…
BSE Filing ↗Board Meeting
Consider and approve Audited (standalone and consolidated) f…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗